Production (Stage)
E
Galmed Pharmaceuticals Ltd. GLMD
$1.60 -$0.01-0.62% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 06/30/2024 06/30/2024 03/31/2024
Total Cash And Short-Term Investments 45.49% 21.27% 5.28% 5.28% -11.04%
Total Receivables 75.98% 26.67% -60.41% -60.41% -55.28%
Inventory -- -- -- -- --
Prepaid Expenses -- 46.98% -- -- --
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets 4.27% 3.42% 2.61% 2.61% 2.63%
Total Current Assets 45.75% 21.79% 2.96% 2.96% -12.87%

Total Current Assets 45.75% 21.79% 2.96% 2.96% -12.87%
Net Property, Plant & Equipment -- -100.00% -- -- -73.67%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -- -- -- -- --
Total Assets 28.67% 11.25% 0.48% 0.48% -1.83%

Total Accounts Payable -5.42% -30.39% -43.79% -43.79% -38.97%
Total Accrued Expenses -- 3.49% -- -- --
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -- -- -- -- --
Total Finance Division Other Current Liabilities 30.63% -- -39.79% -39.79% -28.60%
Total Other Current Liabilities 30.63% -- -39.79% -39.79% -28.60%
Total Current Liabilities 2.38% -20.98% -42.93% -42.93% -36.99%

Total Current Liabilities 2.38% -20.98% -42.93% -42.93% -36.99%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities 2.38% -20.98% -42.93% -42.93% -36.99%

Common Stock & APIC 5.50% 4.79% 3.43% 3.43% 3.46%
Retained Earnings -3.78% -3.90% -3.11% -3.11% -3.38%
Treasury Stock & Other 12.75% 8.37% 34.29% 34.29% 29.46%
Total Common Equity 32.31% 17.64% 11.68% 11.68% 6.39%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 32.31% 17.64% 11.68% 11.68% 6.39%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 32.31% 17.64% 11.68% 11.68% 6.39%